-
The Medicines for Children Research Network: building on current success as we move forward
Sabah G Attar, Vanessa Poustie & Michael W Beresford
Research Update: Clinical Investigation
-
The Medicines for Children Research Network: building on current success as we move forward
Sabah G Attar, Vanessa Poustie & Michael W Beresford
Research Update: Clinical Investigation
-
The Medicines for Children Research Network: building on current success as we move forward
Sabah G Attar, Vanessa Poustie & Michael W Beresford
Research Update: Clinical Investigation
-
The Medicines for Children Research Network: building on current success as we move forward
Sabah G Attar, Vanessa Poustie & Michael W Beresford
Research Update: Clinical Investigation
-
The Medicines for Children Research Network: building on current success as we move forward
Sabah G Attar, Vanessa Poustie & Michael W Beresford
Research Update: Clinical Investigation
-
The Medicines for Children Research Network: building on current success as we move forward
Sabah G Attar, Vanessa Poustie & Michael W Beresford
Research Update: Clinical Investigation
-
The Medicines for Children Research Network: building on current success as we move forward
Sabah G Attar, Vanessa Poustie & Michael W Beresford
Research Update: Clinical Investigation
-
The Medicines for Children Research Network: building on current success as we move forward
Sabah G Attar, Vanessa Poustie & Michael W Beresford
Research Update: Clinical Investigation
-
Sustained and rapid virological responses in hepatitis C clinical trials
Akihito Tsubota, Tomomi Furihata, Yoshihiro Matsumoto, Kan Chiba
Clinical Trail Prospective: Clinical Investigation
-
Sustained and rapid virological responses in hepatitis C clinical trials
Akihito Tsubota, Tomomi Furihata, Yoshihiro Matsumoto, Kan Chiba
Clinical Trail Prospective: Clinical Investigation
-
Sustained and rapid virological responses in hepatitis C clinical trials
Akihito Tsubota, Tomomi Furihata, Yoshihiro Matsumoto, Kan Chiba
Clinical Trail Prospective: Clinical Investigation
-
Sustained and rapid virological responses in hepatitis C clinical trials
Akihito Tsubota, Tomomi Furihata, Yoshihiro Matsumoto, Kan Chiba
Clinical Trail Prospective: Clinical Investigation
-
Sustained and rapid virological responses in hepatitis C clinical trials
Akihito Tsubota, Tomomi Furihata, Yoshihiro Matsumoto, Kan Chiba
Clinical Trail Prospective: Clinical Investigation
-
Sustained and rapid virological responses in hepatitis C clinical trials
Akihito Tsubota, Tomomi Furihata, Yoshihiro Matsumoto, Kan Chiba
Clinical Trail Prospective: Clinical Investigation
-
Sustained and rapid virological responses in hepatitis C clinical trials
Akihito Tsubota, Tomomi Furihata, Yoshihiro Matsumoto, Kan Chiba
Clinical Trail Prospective: Clinical Investigation
-
Sustained and rapid virological responses in hepatitis C clinical trials
Akihito Tsubota, Tomomi Furihata, Yoshihiro Matsumoto, Kan Chiba
Clinical Trail Prospective: Clinical Investigation
-
Novel vaccine technique shows promise in Phase I trial of advanced chronic lymphocytic leukemia
News and Views: Clinical Investigation
-
Novel vaccine technique shows promise in Phase I trial of advanced chronic lymphocytic leukemia
News and Views: Clinical Investigation
-
Novel vaccine technique shows promise in Phase I trial of advanced chronic lymphocytic leukemia
News and Views: Clinical Investigation
-
Novel vaccine technique shows promise in Phase I trial of advanced chronic lymphocytic leukemia
News and Views: Clinical Investigation
-
Novel vaccine technique shows promise in Phase I trial of advanced chronic lymphocytic leukemia
News and Views: Clinical Investigation
-
Novel vaccine technique shows promise in Phase I trial of advanced chronic lymphocytic leukemia
News and Views: Clinical Investigation
-
Novel vaccine technique shows promise in Phase I trial of advanced chronic lymphocytic leukemia
News and Views: Clinical Investigation
-
Novel vaccine technique shows promise in Phase I trial of advanced chronic lymphocytic leukemia
News and Views: Clinical Investigation
-
First drug in over 50 years gains EU approval for stroke prevention in atrial fibrillation
News and Views: Clinical Investigation
-
First drug in over 50 years gains EU approval for stroke prevention in atrial fibrillation
News and Views: Clinical Investigation
-
First drug in over 50 years gains EU approval for stroke prevention in atrial fibrillation
News and Views: Clinical Investigation
-
First drug in over 50 years gains EU approval for stroke prevention in atrial fibrillation
News and Views: Clinical Investigation
-
First drug in over 50 years gains EU approval for stroke prevention in atrial fibrillation
News and Views: Clinical Investigation
-
First drug in over 50 years gains EU approval for stroke prevention in atrial fibrillation
News and Views: Clinical Investigation
-
First drug in over 50 years gains EU approval for stroke prevention in atrial fibrillation
News and Views: Clinical Investigation
-
First drug in over 50 years gains EU approval for stroke prevention in atrial fibrillation
News and Views: Clinical Investigation
-
Fixed combination therapies based on direct renin inhibition: a commentary to the ACCELERATE trial
Giuliano Tocci, Diana Chin, Massimo Volpe
Editorial: Clinical Investigation
-
Fixed combination therapies based on direct renin inhibition: a commentary to the ACCELERATE trial
Giuliano Tocci, Diana Chin, Massimo Volpe
Editorial: Clinical Investigation
-
Fixed combination therapies based on direct renin inhibition: a commentary to the ACCELERATE trial
Giuliano Tocci, Diana Chin, Massimo Volpe
Editorial: Clinical Investigation
-
Fixed combination therapies based on direct renin inhibition: a commentary to the ACCELERATE trial
Giuliano Tocci, Diana Chin, Massimo Volpe
Editorial: Clinical Investigation
-
Fixed combination therapies based on direct renin inhibition: a commentary to the ACCELERATE trial
Giuliano Tocci, Diana Chin, Massimo Volpe
Editorial: Clinical Investigation
-
Fixed combination therapies based on direct renin inhibition: a commentary to the ACCELERATE trial
Giuliano Tocci, Diana Chin, Massimo Volpe
Editorial: Clinical Investigation
-
Fixed combination therapies based on direct renin inhibition: a commentary to the ACCELERATE trial
Giuliano Tocci, Diana Chin, Massimo Volpe
Editorial: Clinical Investigation
-
Fixed combination therapies based on direct renin inhibition: a commentary to the ACCELERATE trial
Giuliano Tocci, Diana Chin, Massimo Volpe
Editorial: Clinical Investigation